Talquetamab
Drug timelines are a Plus or Pro feature.
26 regulatory and trial events tracked for Talquetamab, covering 2025-03-19 to 2026-06-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment [Phase 3]